NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
PHASE1
The purpose of this study is to evaluate the change in the expression of tr...
The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only
PHASE3
This multinational, multicenter, prospective, randomized, controlled, open ...
Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery
EARLY_PHASE1
The purpose of this study is to characterize the reduction in PSMA-avid tum...